Request for Covid-19 Impact Assessment of this Report
The United States Furosemide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Furosemide market, reaching US$ million by the year 2028. As for the Europe Furosemide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Furosemide players cover Sanofi Aventis, US Pharm Holdings, Mylan, and Sandoz, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Furosemide market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection
Solution
Tablet
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi Aventis
US Pharm Holdings
Mylan
Sandoz
Hospira
West-Ward Pharms
Ivax Sub Teva Pharms
Emcure Pharms
Sun Pharm Inds
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Furosemide Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Furosemide by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Furosemide by Country/Region, 2017, 2022 & 2028
2.2 Furosemide Segment by Type
2.2.1 Injection
2.2.2 Solution
2.2.3 Tablet
2.3 Furosemide Sales by Type
2.3.1 Global Furosemide Sales Market Share by Type (2017-2022)
2.3.2 Global Furosemide Revenue and Market Share by Type (2017-2022)
2.3.3 Global Furosemide Sale Price by Type (2017-2022)
2.4 Furosemide Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Clinics
2.4.4 Others
2.5 Furosemide Sales by Application
2.5.1 Global Furosemide Sale Market Share by Application (2017-2022)
2.5.2 Global Furosemide Revenue and Market Share by Application (2017-2022)
2.5.3 Global Furosemide Sale Price by Application (2017-2022)
3 Global Furosemide by Company
3.1 Global Furosemide Breakdown Data by Company
3.1.1 Global Furosemide Annual Sales by Company (2020-2022)
3.1.2 Global Furosemide Sales Market Share by Company (2020-2022)
3.2 Global Furosemide Annual Revenue by Company (2020-2022)
3.2.1 Global Furosemide Revenue by Company (2020-2022)
3.2.2 Global Furosemide Revenue Market Share by Company (2020-2022)
3.3 Global Furosemide Sale Price by Company
3.4 Key Manufacturers Furosemide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Furosemide Product Location Distribution
3.4.2 Players Furosemide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Furosemide by Geographic Region
4.1 World Historic Furosemide Market Size by Geographic Region (2017-2022)
4.1.1 Global Furosemide Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Furosemide Annual Revenue by Geographic Region
4.2 World Historic Furosemide Market Size by Country/Region (2017-2022)
4.2.1 Global Furosemide Annual Sales by Country/Region (2017-2022)
4.2.2 Global Furosemide Annual Revenue by Country/Region
4.3 Americas Furosemide Sales Growth
4.4 APAC Furosemide Sales Growth
4.5 Europe Furosemide Sales Growth
4.6 Middle East & Africa Furosemide Sales Growth
5 Americas
5.1 Americas Furosemide Sales by Country
5.1.1 Americas Furosemide Sales by Country (2017-2022)
5.1.2 Americas Furosemide Revenue by Country (2017-2022)
5.2 Americas Furosemide Sales by Type
5.3 Americas Furosemide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Furosemide Sales by Region
6.1.1 APAC Furosemide Sales by Region (2017-2022)
6.1.2 APAC Furosemide Revenue by Region (2017-2022)
6.2 APAC Furosemide Sales by Type
6.3 APAC Furosemide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Furosemide by Country
7.1.1 Europe Furosemide Sales by Country (2017-2022)
7.1.2 Europe Furosemide Revenue by Country (2017-2022)
7.2 Europe Furosemide Sales by Type
7.3 Europe Furosemide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Furosemide by Country
8.1.1 Middle East & Africa Furosemide Sales by Country (2017-2022)
8.1.2 Middle East & Africa Furosemide Revenue by Country (2017-2022)
8.2 Middle East & Africa Furosemide Sales by Type
8.3 Middle East & Africa Furosemide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Furosemide
10.3 Manufacturing Process Analysis of Furosemide
10.4 Industry Chain Structure of Furosemide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Furosemide Distributors
11.3 Furosemide Customer
12 World Forecast Review for Furosemide by Geographic Region
12.1 Global Furosemide Market Size Forecast by Region
12.1.1 Global Furosemide Forecast by Region (2023-2028)
12.1.2 Global Furosemide Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Furosemide Forecast by Type
12.7 Global Furosemide Forecast by Application
13 Key Players Analysis
13.1 Sanofi Aventis
13.1.1 Sanofi Aventis Company Information
13.1.2 Sanofi Aventis Furosemide Product Offered
13.1.3 Sanofi Aventis Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Aventis Main Business Overview
13.1.5 Sanofi Aventis Latest Developments
13.2 US Pharm Holdings
13.2.1 US Pharm Holdings Company Information
13.2.2 US Pharm Holdings Furosemide Product Offered
13.2.3 US Pharm Holdings Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 US Pharm Holdings Main Business Overview
13.2.5 US Pharm Holdings Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Furosemide Product Offered
13.3.3 Mylan Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Furosemide Product Offered
13.4.3 Sandoz Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Hospira
13.5.1 Hospira Company Information
13.5.2 Hospira Furosemide Product Offered
13.5.3 Hospira Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hospira Main Business Overview
13.5.5 Hospira Latest Developments
13.6 West-Ward Pharms
13.6.1 West-Ward Pharms Company Information
13.6.2 West-Ward Pharms Furosemide Product Offered
13.6.3 West-Ward Pharms Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 West-Ward Pharms Main Business Overview
13.6.5 West-Ward Pharms Latest Developments
13.7 Ivax Sub Teva Pharms
13.7.1 Ivax Sub Teva Pharms Company Information
13.7.2 Ivax Sub Teva Pharms Furosemide Product Offered
13.7.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ivax Sub Teva Pharms Main Business Overview
13.7.5 Ivax Sub Teva Pharms Latest Developments
13.8 Emcure Pharms
13.8.1 Emcure Pharms Company Information
13.8.2 Emcure Pharms Furosemide Product Offered
13.8.3 Emcure Pharms Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Emcure Pharms Main Business Overview
13.8.5 Emcure Pharms Latest Developments
13.9 Sun Pharm Inds
13.9.1 Sun Pharm Inds Company Information
13.9.2 Sun Pharm Inds Furosemide Product Offered
13.9.3 Sun Pharm Inds Furosemide Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sun Pharm Inds Main Business Overview
13.9.5 Sun Pharm Inds Latest Developments
14 Research Findings and Conclusion
Table 1. Furosemide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Furosemide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Solution
Table 5. Major Players of Tablet
Table 6. Global Furosemide Sales by Type (2017-2022) & (MT)
Table 7. Global Furosemide Sales Market Share by Type (2017-2022)
Table 8. Global Furosemide Revenue by Type (2017-2022) & ($ million)
Table 9. Global Furosemide Revenue Market Share by Type (2017-2022)
Table 10. Global Furosemide Sale Price by Type (2017-2022) & (USD/Kg)
Table 11. Global Furosemide Sales by Application (2017-2022) & (MT)
Table 12. Global Furosemide Sales Market Share by Application (2017-2022)
Table 13. Global Furosemide Revenue by Application (2017-2022)
Table 14. Global Furosemide Revenue Market Share by Application (2017-2022)
Table 15. Global Furosemide Sale Price by Application (2017-2022) & (USD/Kg)
Table 16. Global Furosemide Sales by Company (2020-2022) & (MT)
Table 17. Global Furosemide Sales Market Share by Company (2020-2022)
Table 18. Global Furosemide Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Furosemide Revenue Market Share by Company (2020-2022)
Table 20. Global Furosemide Sale Price by Company (2020-2022) & (USD/Kg)
Table 21. Key Manufacturers Furosemide Producing Area Distribution and Sales Area
Table 22. Players Furosemide Products Offered
Table 23. Furosemide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Furosemide Sales by Geographic Region (2017-2022) & (MT)
Table 27. Global Furosemide Sales Market Share Geographic Region (2017-2022)
Table 28. Global Furosemide Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Furosemide Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Furosemide Sales by Country/Region (2017-2022) & (MT)
Table 31. Global Furosemide Sales Market Share by Country/Region (2017-2022)
Table 32. Global Furosemide Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Furosemide Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Furosemide Sales by Country (2017-2022) & (MT)
Table 35. Americas Furosemide Sales Market Share by Country (2017-2022)
Table 36. Americas Furosemide Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Furosemide Revenue Market Share by Country (2017-2022)
Table 38. Americas Furosemide Sales by Type (2017-2022) & (MT)
Table 39. Americas Furosemide Sales Market Share by Type (2017-2022)
Table 40. Americas Furosemide Sales by Application (2017-2022) & (MT)
Table 41. Americas Furosemide Sales Market Share by Application (2017-2022)
Table 42. APAC Furosemide Sales by Region (2017-2022) & (MT)
Table 43. APAC Furosemide Sales Market Share by Region (2017-2022)
Table 44. APAC Furosemide Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Furosemide Revenue Market Share by Region (2017-2022)
Table 46. APAC Furosemide Sales by Type (2017-2022) & (MT)
Table 47. APAC Furosemide Sales Market Share by Type (2017-2022)
Table 48. APAC Furosemide Sales by Application (2017-2022) & (MT)
Table 49. APAC Furosemide Sales Market Share by Application (2017-2022)
Table 50. Europe Furosemide Sales by Country (2017-2022) & (MT)
Table 51. Europe Furosemide Sales Market Share by Country (2017-2022)
Table 52. Europe Furosemide Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Furosemide Revenue Market Share by Country (2017-2022)
Table 54. Europe Furosemide Sales by Type (2017-2022) & (MT)
Table 55. Europe Furosemide Sales Market Share by Type (2017-2022)
Table 56. Europe Furosemide Sales by Application (2017-2022) & (MT)
Table 57. Europe Furosemide Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Furosemide Sales by Country (2017-2022) & (MT)
Table 59. Middle East & Africa Furosemide Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Furosemide Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Furosemide Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Furosemide Sales by Type (2017-2022) & (MT)
Table 63. Middle East & Africa Furosemide Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Furosemide Sales by Application (2017-2022) & (MT)
Table 65. Middle East & Africa Furosemide Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Furosemide
Table 67. Key Market Challenges & Risks of Furosemide
Table 68. Key Industry Trends of Furosemide
Table 69. Furosemide Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Furosemide Distributors List
Table 72. Furosemide Customer List
Table 73. Global Furosemide Sales Forecast by Region (2023-2028) & (MT)
Table 74. Global Furosemide Sales Market Forecast by Region
Table 75. Global Furosemide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Furosemide Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Furosemide Sales Forecast by Country (2023-2028) & (MT)
Table 78. Americas Furosemide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Furosemide Sales Forecast by Region (2023-2028) & (MT)
Table 80. APAC Furosemide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Furosemide Sales Forecast by Country (2023-2028) & (MT)
Table 82. Europe Furosemide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Furosemide Sales Forecast by Country (2023-2028) & (MT)
Table 84. Middle East & Africa Furosemide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Furosemide Sales Forecast by Type (2023-2028) & (MT)
Table 86. Global Furosemide Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Furosemide Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Furosemide Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Furosemide Sales Forecast by Application (2023-2028) & (MT)
Table 90. Global Furosemide Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Furosemide Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Furosemide Revenue Market Share Forecast by Application (2023-2028)
Table 93. Sanofi Aventis Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Aventis Furosemide Product Offered
Table 95. Sanofi Aventis Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 96. Sanofi Aventis Main Business
Table 97. Sanofi Aventis Latest Developments
Table 98. US Pharm Holdings Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 99. US Pharm Holdings Furosemide Product Offered
Table 100. US Pharm Holdings Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 101. US Pharm Holdings Main Business
Table 102. US Pharm Holdings Latest Developments
Table 103. Mylan Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Furosemide Product Offered
Table 105. Mylan Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Sandoz Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 109. Sandoz Furosemide Product Offered
Table 110. Sandoz Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 111. Sandoz Main Business
Table 112. Sandoz Latest Developments
Table 113. Hospira Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 114. Hospira Furosemide Product Offered
Table 115. Hospira Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 116. Hospira Main Business
Table 117. Hospira Latest Developments
Table 118. West-Ward Pharms Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 119. West-Ward Pharms Furosemide Product Offered
Table 120. West-Ward Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 121. West-Ward Pharms Main Business
Table 122. West-Ward Pharms Latest Developments
Table 123. Ivax Sub Teva Pharms Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 124. Ivax Sub Teva Pharms Furosemide Product Offered
Table 125. Ivax Sub Teva Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 126. Ivax Sub Teva Pharms Main Business
Table 127. Ivax Sub Teva Pharms Latest Developments
Table 128. Emcure Pharms Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 129. Emcure Pharms Furosemide Product Offered
Table 130. Emcure Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 131. Emcure Pharms Main Business
Table 132. Emcure Pharms Latest Developments
Table 133. Sun Pharm Inds Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 134. Sun Pharm Inds Furosemide Product Offered
Table 135. Sun Pharm Inds Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 136. Sun Pharm Inds Main Business
Table 137. Sun Pharm Inds Latest Developments
List of Figures
Figure 1. Picture of Furosemide
Figure 2. Furosemide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Furosemide Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Furosemide Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Furosemide Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Solution
Figure 11. Product Picture of Tablet
Figure 12. Global Furosemide Sales Market Share by Type in 2021
Figure 13. Global Furosemide Revenue Market Share by Type (2017-2022)
Figure 14. Furosemide Consumed in Hospital
Figure 15. Global Furosemide Market: Hospital (2017-2022) & (MT)
Figure 16. Furosemide Consumed in Pharmacy
Figure 17. Global Furosemide Market: Pharmacy (2017-2022) & (MT)
Figure 18. Furosemide Consumed in Clinics
Figure 19. Global Furosemide Market: Clinics (2017-2022) & (MT)
Figure 20. Furosemide Consumed in Others
Figure 21. Global Furosemide Market: Others (2017-2022) & (MT)
Figure 22. Global Furosemide Sales Market Share by Application (2017-2022)
Figure 23. Global Furosemide Revenue Market Share by Application in 2021
Figure 24. Furosemide Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Furosemide Revenue Market Share by Company in 2021
Figure 26. Global Furosemide Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Furosemide Revenue Market Share by Geographic Region in 2021
Figure 28. Global Furosemide Sales Market Share by Region (2017-2022)
Figure 29. Global Furosemide Revenue Market Share by Country/Region in 2021
Figure 30. Americas Furosemide Sales 2017-2022 (MT)
Figure 31. Americas Furosemide Revenue 2017-2022 ($ Millions)
Figure 32. APAC Furosemide Sales 2017-2022 (MT)
Figure 33. APAC Furosemide Revenue 2017-2022 ($ Millions)
Figure 34. Europe Furosemide Sales 2017-2022 (MT)
Figure 35. Europe Furosemide Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Furosemide Sales 2017-2022 (MT)
Figure 37. Middle East & Africa Furosemide Revenue 2017-2022 ($ Millions)
Figure 38. Americas Furosemide Sales Market Share by Country in 2021
Figure 39. Americas Furosemide Revenue Market Share by Country in 2021
Figure 40. United States Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Furosemide Sales Market Share by Region in 2021
Figure 45. APAC Furosemide Revenue Market Share by Regions in 2021
Figure 46. China Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Furosemide Sales Market Share by Country in 2021
Figure 53. Europe Furosemide Revenue Market Share by Country in 2021
Figure 54. Germany Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Furosemide Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Furosemide Revenue Market Share by Country in 2021
Figure 61. Egypt Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Furosemide Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Furosemide in 2021
Figure 67. Manufacturing Process Analysis of Furosemide
Figure 68. Industry Chain Structure of Furosemide
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...